Nquyen Khan, Tazi Abdellatif
Service de pneumologie, hôpital Saint-Louis, 75475, Paris 10.
Rev Prat. 2006 Nov 15;56(17):1863-71.
Langerhans' cell histiocytosis (LCH) encompasses a group of disorders of unknown origin with widely variable clinical presentations and outcomes, characterized by the infiltration of the involved tissues by large numbers of Langerhans cells, often organized into granulomas. In adults, localized LCH involves mainly bones and lungs and usually follows a benign course and can regress spontaneously. The clinical presentation of pluritissular LCH is highly variable depending on the organs involved, mainly bones, skin, lungs, pituitary glands and less commonly liver, spleen, hematopoietic and central nervous system. Multisystemic disease carries a poor prognosis in a number of cases, often necessitates the use of aggressive treatments and may induce permanent sequelae. An international collaborative effort is strongly needed in order to enhance knowledge of the pathogenesis of different forms of LCH and accurately manage patients with this orphan disease in adults.
朗格汉斯细胞组织细胞增多症(LCH)是一组病因不明的疾病,临床表现和预后差异很大,其特征是大量朗格汉斯细胞浸润受累组织,这些细胞常形成肉芽肿。在成人中,局限性LCH主要累及骨骼和肺部,通常病程良性,可自发消退。多系统LCH的临床表现高度可变,取决于受累器官,主要是骨骼、皮肤、肺部、垂体,较少累及肝脏、脾脏、造血系统和中枢神经系统。在许多病例中,多系统疾病预后不良,常需采用积极治疗,且可能导致永久性后遗症。为了增进对不同形式LCH发病机制的了解,并准确治疗患有这种成人罕见病的患者,迫切需要开展国际合作。